Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

The lymphoproliferative defect in CTLA-4-deficient mice is ameliorated by an inhibitory NK cell receptor.

Chambers CA, Kang J, Wu Y, Held W, Raulet DH, Allison JP.

Blood. 2002 Jun 15;99(12):4509-16.

2.

A role for the src family kinase Fyn in NK cell activation and the formation of the repertoire of Ly49 receptors.

Lowin-Kropf B, Kunz B, Schneider P, Held W.

Eur J Immunol. 2002 Mar;32(3):773-82.

3.

Impaired anti-viral T cell responses due to expression of the Ly49A inhibitory receptor.

Zajac AJ, Vance RE, Held W, Sourdive DJ, Altman JD, Raulet DH, Ahmed R.

J Immunol. 1999 Nov 15;163(10):5526-34.

4.
5.

Synergistic effects of in vivo depletion of Ly-49A and Ly-49G2 natural killer cell subsets in the rejection of H2(b) bone marrow cell allografts.

Raziuddin A, Bennett M, Winkler-Pickett R, Ortaldo JR, Longo DL, Murphy WJ.

Blood. 2000 Jun 15;95(12):3840-4.

6.
8.

Lymphoproliferative disorder in CTLA-4 knockout mice is characterized by CD28-regulated activation of Th2 responses.

Khattri R, Auger JA, Griffin MD, Sharpe AH, Bluestone JA.

J Immunol. 1999 May 15;162(10):5784-91.

9.

Tyrosine-mediated inhibitory signals contribute to CTLA-4 function in vivo.

Yi LA, Hajialiasgar S, Chuang E.

Int Immunol. 2004 Apr;16(4):539-47.

10.

External and internal calibration of the MHC class I-specific receptor Ly49A on murine natural killer cells.

Kåse A, Johansson MH, Olsson-Alheim MY, Kärre K, Höglund P.

J Immunol. 1998 Dec 1;161(11):6133-8.

11.

NK cell granule exocytosis and cytokine production inhibited by Ly-49A engagement.

Kim S, Yokoyama WM.

Cell Immunol. 1998 Feb 1;183(2):106-12.

PMID:
9606994
12.

CTLA-4 blockade augments human T lymphocyte-mediated suppression of lung tumor xenografts in SCID mice.

Sabel MS, Hess SD, Egilmez NK, Conway TF Jr, Chen FA, Bankert RB.

Cancer Immunol Immunother. 2005 Oct;54(10):944-52. Epub 2005 Apr 22.

PMID:
15846492
13.

Transgenic expression of Ly49A on T cells impairs a specific antitumor response.

Brawand P, Lemonnier FA, MacDonald HR, Cerottini JC, Held W.

J Immunol. 2000 Aug 15;165(4):1871-6.

14.

The MHC class I molecule H-2Dp inhibits murine NK cells via the inhibitory receptor Ly49A.

Olsson-Alheim MY, Sundbäck J, Kärre K, Sentman CL.

J Immunol. 1999 Jun 15;162(12):7010-4.

15.

Expression and functional significance of CTLA-4, a negative regulator of T cell activation.

Kosmaczewska A, Ciszak L, Boćko D, Frydecka I.

Arch Immunol Ther Exp (Warsz). 2001;49(1):39-46. Review.

PMID:
11266089
16.

HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells.

Mingari MC, Ponte M, Bertone S, Schiavetti F, Vitale C, Bellomo R, Moretta A, Moretta L.

Proc Natl Acad Sci U S A. 1998 Feb 3;95(3):1172-7.

17.

NK cell receptor calibration: effects of MHC class I induction on killing by Ly49Ahigh and Ly49Alow NK cells.

Olsson-Alheim MY, Salcedo M, Ljunggren HG, Kärre K, Sentman CL.

J Immunol. 1997 Oct 1;159(7):3189-94.

PMID:
9317116
18.

Structure/function relationship of activating Ly-49D and inhibitory Ly-49G2 NK receptors.

Ortaldo JR, Winkler-Pickett R, Willette-Brown J, Wange RL, Anderson SK, Palumbo GJ, Mason LH, McVicar DW.

J Immunol. 1999 Nov 15;163(10):5269-77.

19.

Ly49A expression on T cells alters T cell selection.

Fahlén L, Oberg L, Brännström T, Khoo NK, Lendahl U, Sentman CL.

Int Immunol. 2000 Feb;12(2):215-22.

20.

Expression of Ly49A on T cells alters the threshold for T cell responses.

Oberg L, Eriksson M, Fahlén L, Sentman CL.

Eur J Immunol. 2000 Oct;30(10):2849-56.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk